Search
Legacy Heritage Fund 
Meeting Supporters:

Rules for preparation and submission of Abstracts

Preparation and Submission of Abstracts 

·         Submission of an abstract constitutes a commitment to present it if accepted. Failure to present, if not justified, will jeopardize future acceptance of abstracts. 

·         The presenting (first) author of accepted abstract must register for the meeting 

·         There is no limit to the number of abstracts a research group can submit  

Title:
Abstracts should have a concise title using only widely-known abbreviations (i.e. GFP, CNS). 

Please use Arial font, 12 point and bold, center the title, and use standard sentence capitalization (only the first letter of the first word of the abstract should be capitalized). For example: 

Regeneration of complete human arms from fingernail stem cells. 

Author Name(s) 

  • The submitting author should be the first and presenting author. Please list the senior author last.  
  • Names should be in Arial font, 12 point 
  • List full names (not initials), with the presenting author’s first name first, and other authors last name first. Separate author’s names with commas, and use the word “and” before the last author. 
  • Underline the first author’s (presenting author’s) name. For example: 

Ploni Alomoni, Smith, John, and Investigator, Principal.  

Abstract Data 

  • All abstracts are to be written in English. Please have a native English speaker check for correct grammar if possible. Proofread abstracts carefully in addition to using the spellchecker feature of a word processing program.    

Abstract Text 

  • Use Arial 12 point. 
  • Abstracts are limited to 1,950 characters (about 300-350 words) not including spaces. This number includes the text plus any graphic/table, but not the title or authors. Inclusion of a table or graphic reduces the allowed number of characters by 250.   
  • The text should include: the objective(s) of the study, an outline of methods if pertinent, the central findings and a conclusion/implication statement.  
  • Avoid using “jargon” specific to your area (i.e. use “action potentials” and not “spikes”). 
  • Use generic drug names.  
  • Standard abbreviations may be used without definition. Non-standard abbreviations (kept to a minimum) should be placed in parentheses after the first use of the word or phrase abbreviated.  
  • Do not include references, acknowledgments or grant support.  

Abstract Acceptance 

Notification of abstract acceptance status will be email at the end of November. 
Please ensure that the email provided is accurate since all correspondences will be via e-mail.
 

PrintTell a friend

GoDaddy
Jump to page content